IDEXX Laboratories, Inc. (IDXX) Covered Calls

IDEXX Laboratories, Inc. covered calls IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, software, and water testing. Headquartered in Westbrook, Maine, the company develops and manufactures instrument-based diagnostic test systems and cloud-based software solutions for the companion animal, livestock, and poultry industries. IDEXX specializes in enhancing animal health and productivity through its extensive reference laboratory network and advanced point-of-care diagnostic equipment.

You can sell covered calls on IDEXX Laboratories, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IDXX (prices last updated Fri 4:16 PM ET):

IDEXX Laboratories, Inc. (IDXX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
573.82 +2.61 565.00 576.00 443K 44 46
Covered Calls For IDEXX Laboratories, Inc. (IDXX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Mar 20 570 12.30 563.70 1.1% 50.2%
Apr 17 570 25.20 550.80 3.5% 35.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


IDEXX Laboratories, Inc. (IDXX) is the dominant force in the global veterinary diagnostics market, operating an integrated ecosystem of hardware, consumables, and software. Its business model is built on a high-margin recurring revenue engine, where the placement of proprietary diagnostic instruments (the "VetLab" suite) drives the continuous sale of high-volume testing consumables. This is augmented by a global network of reference laboratories and an industry-leading veterinary software-as-a-service (SaaS) platform, including ezyVet and Cornerstone.

By early 2026, IDEXX has successfully weathered a period of softer veterinary visit volumes by increasing the "diagnostic intensity" per visit. A major milestone in early 2026 was the North American rollout of its expanded Cancer Dx panel, which provides early detection for mast cell tumors in dogs. Additionally, the company launched the ImageVue DR50 Plus, setting a new standard for low-dose digital radiography in clinical settings. Management has emphasized its "Pure-Play Pet" advantage, prioritizing investments in AI-driven diagnostics and cloud-based imaging to ensure that IDEXX remains the indispensable technology backbone for modern veterinary practices worldwide.

Competitive Landscape

The competitive landscape for IDEXX consists of global animal health corporations and emerging biotechnology firms. Primary rivals that are publicly traded on the NYSE or NASDAQ and offer highly active options markets include Zoetis Inc. and Elanco Animal Health Incorporated. While Zoetis is the world leader in animal medicines and vaccines, it competes directly with IDEXX in the rapidly growing point-of-care diagnostics sector.

Other notable competitors in the healthcare and life sciences sectors with active options trading include Danaher Corporation (via its diagnostics segments) and Thermo Fisher Scientific Inc.. IDEXX distinguishes itself through its comprehensive software integration; by owning the practice management software that vets use daily, IDEXX creates a technological moat that makes switching to a competitor’s diagnostic hardware operationally difficult. This integration, combined with its high-quality reference lab results, allows IDXX to command a premium valuation and maintain high customer retention rates even in fluctuating economic environments.

Strategic Outlook

Strategic innovation is currently focused on Preventative Care and Early Detection, leveraging massive datasets to identify chronic conditions in pets years before clinical symptoms appear. The company is prioritizing the expansion of its International Reference Lab Network, particularly in emerging markets where pet ownership and care standards are rising rapidly. These efforts are designed to reduce the portfolio's sensitivity to U.S.-specific macroeconomic trends while capturing long-term global growth in pet spending.

The long-term outlook involves a commitment to a disciplined capital allocation strategy that emphasizes research and development and strategic "tuck-in" acquisitions. Management is prioritizing Operational Efficiency and Margin Expansion, utilizing automation within its lab network to offset labor inflationary pressures. By leveraging its dominant installed base and its pioneering role in veterinary AI, IDEXX Laboratories, Inc. aims to remain the definitive leader in animal health technology, providing consistent compounding growth for its shareholders.

 
Top 10 Open Interest For Mar 20 Expiration     Top 5 High Yield
1.NVDA covered calls 6.QQQ covered calls   1.CTMX covered calls
2.SLV covered calls 7.EWZ covered calls   2.PL covered calls
3.SPY covered calls 8.IWM covered calls   3.RCAT covered calls
4.EEM covered calls 9.FXI covered calls   4.AXTI covered calls
5.IBIT covered calls 10.KWEB covered calls   5.LUNR covered calls

Want more examples? |

Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.

Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.

No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.

You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.